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Equine neosporosis is caused by an obligatory intracellular 
apicomplexan protozoan parasite, Neospora caninum. N. cani-
num belongs to the family Sarcocystidae and closely resembles 
Toxoplasma gondii [1]. Neospora hughesi is a second species of 
Neospora described in the horse [2]. The parasite infects a 
broad range of animals including cattle, sheep, goats, deer, 
horses, and dogs. Although N. caninum is an important cause 
of abortion in cows, as well as various congenital abnormali-
ties in dogs, little is known regarding its pathogenicity and 
transmission in horses [3]. Exposure to Neospora spp. in horses 
is not uncommon, clinical disease associated with natural in-
fections in adult horses, however, have been reported in only 
few cases. Moreover, it is uncertain whether N. caninum, N. 
hughesi, or both are responsible for the disease in positive cases 
since both species cross-react serologically [4]. In horses, infec-
tion with Neospora spp. has been associated with neurological 
disorders, neonatal diseases, and abortion [5]. Various labora-
tory techniques have been used to diagnose N. caninum-infect-
ed animals. Immunohistochemistry is used to demonstrate N. 
caninum in the placenta or fetal tissues [6]. Serology tests such 
as indirect fluorescent antibody test (IFAT), immunoblotting 
(IB), direct agglutination tests, and a wide variety of ELISAs are 
used to detect specific antibodies in sera of infected animals. 
In addition, DNA biotechnology can be used to distinguished 
N. hughesi from N. caninum [7].
According to the Jordan Ministry of Agriculture Yearly Statis-
tical Data (2007), the total population of horses is 2,182 heads. 
In Jordan, the prevalence and risk factors associated with N. 
caninum infection has been reported in dairy herds [8]. Infor-
mation regarding the prevalence of Neospora spp. in horses is 
lacking, therefore, the purpose of the study reported here was 
to determine the seroprevalence of Neospora spp. in horses and 




Korean J Parasitol Vol. 53, No. 2: 163-167, April 2015 
http://dx.doi.org/10.3347/kjp.2015.53.2.163▣ORIGINAL ARTICLE 
•  Received 26 November 2014, revised 19 January 2015, accepted 25 January 
2015.
*Corresponding author (talafha@just.edu.jo)
© 2015, Korean Society for Parasitology and Tropical Medicine
This is an Open Access article distributed under the terms of the Creative Commons 
Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) 
which permits unrestricted non-commercial use, distribution, and reproduction in any 
medium, provided the original work is properly cited.
Seroprevalence and Potential Risk Factors Associated 
with Neospora spp. Infection among Asymptomatic 
Horses in Jordan
Abdelsalam Q. Talafha1,*, Sameeh M. Abutarbush1, David L. Rutley2
1Department of Veterinary Clinical Sciences, Faculty of Veterinary Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan; 
2School of Animal and Veterinary Science, The University of Adelaide, South Australia, Australia
Abstract: This study aimed to determine the seroprevalence and to identify risk factors associated with Neospora spp. 
infection in horses in Jordan. Management related data were collected from each farm and individual horses. Sera from 
227 horses from 5 of 6 climatic regions in Jordan were analyzed for the presence of antibodies to Neospora spp. by ELI-
SA kit. The study was performed during spring of 2010. The association between seropositivity and risk factors was ana-
lyzed. A total of 7 (3%) of 227 sera had antibodies for Neospora spp. There was a significant regional difference (P=0.018) 
between the 5 climatic regions. Positive cases were located in Amman and Irbid, while the other regions (Zarqa, Jordan 
Valley, and Wadi Mousa) had zero prevalence. The use of anthelmintics at least once a year resulted in a significant reduc-
tion of the seroprevalence to Neospora spp. (1.6% vs 9.8%). However, this might be a phenomenon by chance and a 
better hygiene since owners can invest in anthelmintics. Other risk factors such as age, gender, breed, usage, body con-
dition score, grazing, presence of other animals mixed with the horses in the same property, and a history of previous dis-
eases were not significantly associated with the seroprevalence to Neospora spp. infection. This is the first study to report 
on the presence of Neospora seropositive horses in Jordan. Further studies are warranted to better understand the role of 
certain risk factors in the transmission of Neospora spp. among horse population and to determine which Neospora spp. 
are responsible for the infection.
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MATERIALS AND METHODS
Study animals and design
Total 227 clinically normal horses were enrolled in the 
study. The horse farms were selected randomly using the re-
cords of the Jordanian Ministry of Agriculture. Horses from 
each farm were selected randomly using a table of random 
digits. Horses sampled for the study were from 5 of 6 climatic 
regions in Jordan; Amman, Irbid, Zarqa, Jordan Valley, and 
Wadi Mousa (Fig. 1). The 6th region was not sampled due to 
the lack of horse population. About 40-50 horses were sam-
pled from each region. The study was performed during spring 
of 2010. Each farmer was interviewed to gather information 
about each horse, farm characteristics, and herd management. 
Table 1 shows a list of specific data that was collected on each 
horse and the farm included in the study.
Blood samples
Whole blood (5 to 10 ml) was collected from the jugular 
vein of each horse using vacuum plain tubes (Ayset tube®, Ad-
ana, Turkey) and transported on ice to the laboratory within 2 
hr. Blood was centrifuged at 5,000 g for 10 min, and sera were 
harvested and stored in microtubes at -20˚C until analyzed.
Laboratory analysis
For determination of Neospora spp. seroprevalence, antibod-
ies in sera were detected by an indirect ELISA kit (The Herd-
Chek Anti-Neospora caninum Antibody Test Kit®, IDEXX Labo-
ratories, Westbrook, Maine, USA) according to the manufac-
turer’s instructions. The test has a known sensitivity and speci-
ficity of 98.6% and 98.9%, respectively. The resulted preva-
lence was adjusted to the test sensitivity and specificity using 
the formula published previously [9].
Statistical analysis
The seroprevalence and risk factor analysis of Neospora spp. 
infection were determined using the chi square tests of associa-
tion [10]. Variables with a P-value of <0.05 were considered 
statistically significant.
RESULTS
Table 1 shows the distribution of Neospora spp. positive and 
negative horses (n=227) from Jordan with various risk factors 
that might be associated with the seropositivity to equine neo-
sporosis. The overall seroprevalence of Neospora spp. was 3% 
(7/227 horses). There was a significant regional difference 
(P=0.018) with the positive cases belonging to Amman and 
Irbid. The following risk factors were not significantly (P>0.05) 
associated with seroprevalence of Neospora spp.: horse age, gen-
der, breed, usage, body condition score on a scale of 1-9 (a 
score of 1 represents emaciation whereas a score of 9 is a pro-
found obesity), grazing, presence of other animals mixed with 
the horses in the same property, and a history of previous dis-
eases such as gastrointestinal (colic and diarrhea), respiratory 
(fever, coughing, naso-ocular discharge), integumentary (der-
matitis), and musculoskeletal diseases (lameness) since 1 year 
before the commencement of the study. Of 227 horses, 186 
(82%) received anthelmintic medication at least once or more 
a year. Ivermectin and/or piprazine were the most commonly 
used anthelmintics. Greater than or equal to 1 deworming per 
year was significantly (P=0.0017) associated with a reduction 
in the seroprevalence of Neospora spp. (1.6% vs 9.8%). This 
finding was supported by an effect of any drench reducing the 
seroprevalence of Neospora spp. (P=0.0063). Of 186 horses 
drenched, only 3 cases (1.6%) of Neospora infection were iden-
Fig. 1. Map of Jordan divided into 6 climate regions according to 
the model of Koppen (anon., 1984). It also indicates the location 
of 5 sites sampled in this study. 1. Warm temperature rainy (Irbid), 
2. Cool steppe (Amman), 3. Cool desert (Zarqa), 4. Warm desert 
(Jordan Valley), 5. Cool temperate rainy (Wadi Mousa), and 6. 
Warm steppe (not sampled).
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tified. In contrast, the other 4 cases of Neospora infection were 
identified from 41 horses (9.8%) that had not been drenched 
for worms. Testing the association of specific anthelmintic 
drugs with the seroprevalence of Neospora spp. was not possible 
due to the low seroprevalence of Neospora. 
DISCUSSION
Neosporosis in horses has been reported from different 
parts of the world. To the authors’ knowledge, this is the first 
study in Jordan to determine the prevalence of antibodies to 
Neospora spp. and to evaluate risk factors associated with the 
occurrence of neosporosis in horses. Unfortunately, we were 
unable to determine which Neospora spp. were infected the se-
ropositive horses since both species cross-react serologically 
[4]. The results of this study indicated that horses in Jordan are 
exposed to Neospora spp. with an overall seroprevalence of 3%. 
This percentage is considerably lower than the seroprevalence 
Table 1. Regional distribution of Neospora spp. positive and negative horses (n=227) from Jordan and the risk factors analysis associ-
ated with the occurrence of equine neosporosis
Variable
Description Neospora spp.(%)












































































Body condition score (scale 1-9)
Under condition <4
Normal condition 4-5.5
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of Neospora infection that have been reported in horses from 
the United States [11] and Czech Republic [12]. In the Middle 
East, seroprevalence of Neospora spp. was reported from Israel 
[13] and Saudi Arabia [14]. The seroprevalence of Neospora 
spp. infection in horses is considerably different among and 
within countries. These variations might be due to differences 
in the serological tests used in each study, limitations of the 
testing methods, and non-standardized controls, and cut-off 
values applied [15]. In addition, the study design, criteria for 
sample collection, different levels of exposure to the various 
risk, and protective factors for infection or disease might influ-
ence the seroprevalence of Neospora spp. which make the com-
parison between results from different studies difficult [16]. 
Determining various risk factors and understanding their 
role in disease transmission and epidemiology is critical for 
the development and implementation of proper measures to 
control equine neosporosis. The seroprevalence of Neospora 
spp. was higher in Amman and Irbid compared to other cli-
matic regions of the country. It was noticed that these 2 re-
gions have the highest density of horse population in Jordan. 
Significant differences in the seroprevalence of Neospora spp. 
among horse groups from various geographical regions were 
reported from USA [15]. However, no significant difference 
was found in the seropositivity rates from 4 districts in Niğde 
province of Turkey [17]. 
The present study showed a non-significant decrease in the 
seroprevalence of Neospora spp. with increased horse age. This 
result is contrary to the previous report from Israel [13] which 
found a significantly higher seroprevalence to Neospora spp. as 
horses get older than 10 years of age (because of an increased 
likelihood of exposure through horizontal transmission over 
time). In a Turkish study, a non-significant increase of serop-
revalence to Neospora spp. (22.2% and 27.2%) was found be-
tween 2 age groups; 1-10 and 11-20 years old, respectively [17]. 
The absence of significant effect for the gender on the serop-
revalence of Neospora spp. in this study is in agreement with 
findings of Villalobos et al. [18]. The horse breed was also not 
significantly associated with the seroprevalence to Neospora 
spp. which agrees with the study of Kligler et al. [13] in Israel. 
The presence of other animals mixed-in with horses in the 
same property was also not significantly associated with serop-
revalence to Neospora spp. In cattle, it is generally accepted that 
the presence of farm dogs, the definitive host for N. caninum, 
increases the chance of N. caninum infection [19]. The present 
study showed that the use of anthelmintic medication at least 
once a year resulted in a significant reduction in the seropreva-
lence of Neospora spp. However, this might be a phenomenon 
by chance and a better hygiene since owners can invest in an-
thelmintics. In cattle, various antimicrobial agents have been 
tested against N. caninum in vitro but there is still no safe and 
effective chemotherapy that clears infection completely [20]. 
However, in vitro and in vivo experimental studies have shown 
a promising effect for toltrazuril and ponazuril on tachyzoites 
of N. caninum in calves [21]. Further studies are necessary to 
determine which species, N. caninum or N. hughesi, infect the 
horses. Furthermore, detailed studies to better understand vari-
ous risk factors that affect the transmission of the parasite 
among horses are warranted.
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